Type II transmembrane serine proteases in development and disease.
about
A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entryHATL5: a cell surface serine protease differentially expressed in epithelial cancersDevelopment and characterization of new peptidomimetic inhibitors of the West Nile virus NS2B-NS3 proteaseCleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitorsMatriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses.Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium.Laminin-332 cleavage by matriptase alters motility parameters of prostate cancer cells.Characterization and expression analysis of chymotrypsin after bacterial challenge in the mud crab, Scylla paramamosain.Expression and genetic loss of function analysis of the HAT/DESC cluster proteases TMPRSS11A and HATTMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells.Cleavage specificity analysis of six type II transmembrane serine proteases (TTSPs) using PICS with proteome-derived peptide librariesMembrane-type MMPs are indispensable for placental labyrinth formation and development.Clinical significance of TMPRSS4 in prostate cancer.Matriptase and MET are prominently expressed at the site of bone metastasis in renal cell carcinoma: immunohistochemical analysis.c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptaseThe expression of TMPRSS4 and Erk1 correlates with metastasis and poor prognosis in Chinese patients with gastric cancerNrf2 expression modifies influenza A entry and replication in nasal epithelial cells.The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis.Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survivalEnergetic and structural basis for activation of the epithelial sodium channel by matriptaseThe cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.Membrane-anchored serine proteases in health and disease.Cell Surface Human Airway Trypsin-Like Protease Is Lost During Squamous Cell Carcinogenesis.Type II transmembrane serine proteases as potential targets for cancer therapy.Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality.Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs).Proteases: multifunctional enzymes in life and disease.Matriptase: a culprit in cancer?Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasisTMPRSS4 regulates levels of integrin α5 in NSCLC through miR-205 activity to promote metastasis.TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability.Membrane Proteins Involved in Epithelial-Mesenchymal Transition and Tumor Invasion: Studies on TMPRSS4 and TM4SF5.Overexpression of TMPRSS4 promotes tumor proliferation and aggressiveness in breast cancerHepatocyte growth factor activator (HGFA): pathophysiological functions in vivo.The matriptase-prostasin proteolytic cascade in epithelial development and pathology.Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium.Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.TMPRSS4: an emerging potential therapeutic target in cancer.The basal chorionic trophoblast cell layer: An emerging coordinator of placenta development.Decreasing the ratio of matriptase/HAI‑1 by downregulation of matriptase as a potential adjuvant therapy in ovarian cancer.
P2860
Q24306622-7824DC7B-2CDA-4887-93A8-055FE1CE2107Q24329267-CB3C0B28-B3EF-4E36-963D-D16979BD84C6Q27683750-7FEA9F8E-359D-428A-B60B-799701084592Q30386796-1535A030-B02F-499F-9C47-27B9B603480DQ30424187-14B224EA-C30F-4020-BA62-EDC17021EE9DQ30426551-F58CF4A0-F81F-42F7-8F28-A29157CE5EB4Q30540234-97420E33-8C63-489C-AEE1-576FE419D120Q33890353-3C191562-6565-48FB-B055-2ECA7C809E6EQ33997003-751AF3D3-F137-4A4E-92BA-25BBC96810CFQ34120814-C12EB04D-860C-4B9D-A6B3-F10CCD29B555Q34165943-A0F8C262-DBC9-43CF-A76E-30E8B8277167Q34541784-A8DE8AEA-B710-4036-91C3-2009E9C52A9FQ34733038-5E87944E-7287-4BE7-A1E6-F291583B2B9DQ34854941-0485B953-F016-494C-9A0D-5DAFFD565B36Q34883707-30C2EA45-F146-4031-9F19-B74FBAAA1AF1Q34906835-3F1EF661-1A0D-48EA-951F-06B9602B8744Q35103126-B592F66F-0118-4B7B-BDFA-226F59963E8EQ35224818-6A6DCA56-496B-495E-8E32-D608637554BBQ35642678-9B86FA9E-155A-4535-9F8D-D41B9F1E3D04Q36113414-5D53CA54-A515-42AB-AFAA-7C99AD9A78BEQ36923138-80E457AE-04E1-48F8-A230-FFFD61DB5DADQ36969010-3DD8C7CC-FB38-4719-9630-C4C461184F0AQ37066934-E2FA6FED-2E61-4525-81E4-233A1FBC7586Q37168351-3DC055DE-E73D-4BFE-9F9E-57FC79A4D628Q37197314-44C92017-8C98-491C-9348-6F78D15B8A9BQ37216570-AA1F7605-8C57-466A-9291-124D08952379Q37225060-8652F533-22CA-4822-812F-0BA11A4C1339Q37401353-37C04780-01EC-46FB-A99B-2E06A3ABDE9AQ37450622-A367AB1B-397A-434A-9A98-B0E1EA8CA0C8Q37559017-2A43DA91-0BEF-458A-8539-86257752B254Q37683046-A8C016C6-E201-4855-8688-04CBE6BCDB04Q37709042-6161093D-26AB-497F-95FB-02FC6946892FQ37714123-67B41D65-D9C3-4909-84C5-7C84B9D19953Q37733681-BC8D9864-E7E0-491A-A51B-83840C72C509Q37986624-E536D5D9-9903-4256-8C18-D1AF3BA189F0Q38118946-9B27BE62-FE69-440E-A107-5FF210518033Q38184632-A9023C70-7625-49DF-9BC8-250DA8E60CF1Q38247387-8B15B52A-B6F4-44D5-8EEA-58F0796BF599Q38700458-C9CCD075-6BFA-49C9-BB80-5BD39ADE2543Q38760934-2E9112F4-B748-4E5D-B0C9-F35EE8AB6B85
P2860
Type II transmembrane serine proteases in development and disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Type II transmembrane serine proteases in development and disease.
@en
Type II transmembrane serine proteases in development and disease.
@nl
type
label
Type II transmembrane serine proteases in development and disease.
@en
Type II transmembrane serine proteases in development and disease.
@nl
prefLabel
Type II transmembrane serine proteases in development and disease.
@en
Type II transmembrane serine proteases in development and disease.
@nl
P1476
Type II transmembrane serine proteases in development and disease.
@en
P2093
Roman Szabo
P304
P356
10.1016/J.BIOCEL.2007.11.013
P577
2007-12-04T00:00:00Z